BiotechTube
Amaros

Amaros

San Francisco, United States· Est.
amaros.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

Amaros is a private, early-stage company founded in 2021, focusing on applying AI and machine learning to ophthalmology data. Its core offering is the AmarosEngine™, a closed-system platform that unifies and analyzes real-world ophthalmic data to generate evidence-based insights. The company targets three primary customer segments: clinical practices (for operational efficiency and patient care), clinical trial sponsors/CROs (for study optimization and enrollment), and life sciences commercial teams (for market strategy). As a platform company, it appears to be in an early-revenue phase, building its network of provider clinics and technology partners.

Ophthalmology

Technology Platform

AmarosEngine™: A proprietary, closed-system precision intelligence platform that integrates and unifies EHR, practice management, and imaging data from ophthalmology clinics. It uses ophthalmology-specific machine learning algorithms to generate real-time, actionable insights for clinical practice, clinical trials, and commercial strategy.

Funding History

1
Total raised:$5M
Seed$5M

Opportunities

The large and growing ophthalmology market, combined with the industry's critical need for efficient clinical trial recruitment and high-quality real-world evidence, presents a significant opportunity.
Amaros's focused, closed-loop platform is well-positioned to become the essential data infrastructure for this specialty, enabling faster drug development and improved patient care.

Risk Factors

Key risks include the challenge of achieving critical mass in its provider network, the technical complexity of maintaining seamless integrations across diverse clinic IT systems, and navigating stringent data privacy and regulatory requirements for health data.
Competition from larger healthcare data aggregators also poses a threat.

Competitive Landscape

Amaros competes in a niche but potentially crowded space. It faces potential competition from large healthcare data and CRO companies (e.g., IQVIA) expanding into specialty areas, EHR vendors developing their own analytics, and other AI-powered imaging startups. Its key differentiators are its exclusive ophthalmology focus, closed-system data architecture, and proprietary domain-specific algorithms.

More companies in Digital Health & Biotech SaaS →More companies in United States →